SOLID BIOSCIENCES INC. — Income Charts
24 quarters of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Operating Expenses
Income Breakdown
Revenue↓-40.6% -$6M
$8M
R&D↑+45.9% +$7M
$21M
D&A↓-29.1% -$221K
$539K
Operating Income↓-17.2% -$3M
$-21M
EBITDA↓-29.1% -$221K
$539K
Interest Expense↑+0.0% +$0
$-13K
Interest Income
$2M
Tax Provision
$0
Net Income↓-13.5% -$2M
$-20M
DTA Valuation Allowance↑+31.3% +$35M
$147M
Tax Credit Carryforwards↑+31.4% +$10M
$41M
NOL Carryforwards↑+20.9% +$11M
$61M
ETR (Continuing Operations)↑+0.0pts
0.0%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↑+1.0pts
7.4%
Operating Lease Cost
$522K
Revenue YoY Variation
-40.6%
Income YoY Variation↓-32.3pts
-17.2%
Income QoQ Variation↑+13.2pts
16.7%